Capital Markets Day 2023
Ipsen hosted a capital-markets day on 7 December 2023, at The Brewery, London.
A replay of the event is available below.
Capital Markets Day – Webcast Replay
Speakers
As well as an opportunity to meet management, the event focused on R&D strategy, pipeline opportunities, the drivers of key on-market medicines, as well as a mid-term outlook.
IPSEN IN BRIEF
Our vision is to be a leading global mid-sized biopharmaceutical company with a focus on transformative medicines in Oncology, Rare Disease and Neuroscience.
Discover Ipsen in two pages: our medicines and key figures, our objectives and our strategy.
Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to: paula.brooks@ipsen.com
Your dedicated contacts
-
Craig Marks
Vice President, Investor Relations
-
-
Nicolas Bogler
Senior Manager, Investor Relations
-
Q1 2024 sales update
Applications now open for the 2024 Golden Ticket competition
FY 2023 results announcement
Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics
Examining the European Pharma legislation: EFPIA publishes the Dolon Report
2023 year to date and third-quarter sales results
Winner of Ipsen’s golden ticket announced as newest resident of Biolabs Hôtel Dieu
David Loew, Philippe Lopes Fernandes inaugurate Biolabs – Hôtel Dieu
Ipsen’s 2022 Integrated Annual Report now available
